• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 15 Jul

    SG BLOCKS ANNOUNCES SHARE REPURCHASE PROGRAM AND SIGNING OF LETTER OF INTENT FOR SALE OF LAGO VISTA DEVELOPMENT SITE

    Board Authorizes Repurchase of up to 500,000 Shares and Sale of Lago Vista at Asking Price JACKSONVILLE, Fla.--(BUSINESS WIRE)-- SG Blocks, Inc. (NASDAQ: SGBX) ("SG Blocks" or the "Company"), a leading developer, designer, and fabricator of modular structures, today announced that its Board of Directors has authorized a share repurchase… Read More..

    Share this:
  • 8 Jul

    ProMIS Neurosciences to Commence Trading on Nasdaq Under the Symbol “PMN”

    TORONTO, Ontario and CAMBRIDGE, Massachusetts, July 08, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN) (TSX: PMN) (“ProMIS” or the “Company”), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers, implicated in the development of neurodegenerative diseases, today announced… Read More..

    Share this:
  • 6 Jul

    Quoin Pharmaceuticals Announces Opening of First Clinical Site for Netherton Syndrome Clinical Study

    Three Arm, Randomized, Double-Blind, Vehicle Controlled Study Will Test Two Doses of QRX003 Versus Vehicle ASHBURN, Va., July 06, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, announces that the first clinical site has now… Read More..

    Share this:
« Previous 1 … 16 17 18 19 20 … 295 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact